TRANSDERMALES PFLASTER

Patent europeic · EP3932489 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3932489
Numer da la dumonda
EP20762445
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
21-02-2020
Publitgà
05-01-2022
Concedì
25-10-2023
Stritgà
24-09-2024
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/70 (2006.01)
A61P 29/00 (2006.01)
A61K 47/20 (2006.01)
A61K 47/32 (2006.01)
A61K 31/196 (2006.01)
Prioritad
JP 2019034363 27.02.2019
Dumonda PCT
PCT/JP2020/007182 21.02.2020
Publicaziun PCT
WO2020/175395 03.09.2020
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-09-2024

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.09.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.09.2024

  2. 04-09-2024

    Midada

    Published in Swissreg on 04.09.2024

  3. 25-10-2023

    Concedì

    Published in Swissreg on 25.10.2023

Partidas

Possessur

Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co., Inc.

408, Tashirodaikan-machi, Tosu-shi, Saga 841-0017, JP

Inventur

KURITA, Hisakazu

Tosu-shi, Saga 841-0017, JP

KAMAKURA, Naoto

Tosu-shi, Saga 841-0017, JP

TAKEUCHI, Akio

Tosu-shi, Saga 841-0017, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.